---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-26-000025"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2026-05-19T20:21:39+00:00"
generated_at: "2026-05-19T20:24:27.917968+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# AtriCure shareholders approve share increases for 2023 Stock Incentive Plan and 2018 ESPP

## Summary
- Shareholders approved amendment to 2023 Stock Incentive Plan, increasing authorized shares from 4.5M to 6M.
- Shareholders approved amendment to 2018 Employee Stock Purchase Plan, increasing authorized shares by 750,000.
- All nine director nominees elected; Deloitte ratified as auditor; say-on-pay approved with over 40M votes.
- Stock plan amendment passed with ~41M for vs 1.1M against; broker non-votes of 3.8M.

## SEC filing metadata
- accession: 0001323885-26-000025
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2026-05-19T20:21:39+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388526000025/0001323885-26-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388526000025/atrc-20260518.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-26-000025
- JSON: https://secwatch.observer/filing/0001323885-26-000025.json
- Plain text: https://secwatch.observer/filing/0001323885-26-000025.txt

## Key facts
- Shareholder Votes
  AtriCure, Inc. shareholders approved Approve amendment to AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase number of shares by 750,000.
  - Proposal: equity plan
  - Outcome: passed
  source text: 4. The stockholders approved the amendment to the AtriCure, Inc. 2018 Employee Stock Purchase Plan to increase the number of shares of common stock authorized by 750,000. For: 42,064,798 Against: 109,893 Abstain: 6,457 Broker Non-Votes: 3,820,943
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388526000025/0001323885-26-000025-index.htm
- Shareholder Votes
  AtriCure, Inc. shareholders approved Election of nine directors to serve one-year terms expiring at the 2027 Annual Meeting of Stockholders.
  - Proposal: director election
  - Outcome: passed
  source text: Director Nominees For Against Abstain Broker Non-Votes Michael H. Carrel 41,848,141 264,297 68,710 3,820,943 Regina E. Groves 41,852,934 258,662 69,552 3,820,943 B. Kristine Johnson 41,685,893 426,149 69,106 3,820,943 Shlomo Nachman 41,846,048 260,889 74,211 3,820,943 Karen N. Prange 41,514,921 590,763 75,464 3,820,943 Deborah H. Telman 40,917,973 1,192,573 70,602 3,820,943 Sven A. Wehrwein 41,454,342 653,542 73,264 3,820,943 Robert S. White 41,025,795 1,086,032 69,321 3,820,943 Maggie Yuen 41,447,687 663,914 69,547 3,820,943
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388526000025/0001323885-26-000025-index.htm
- Shareholder Votes
  AtriCure, Inc. shareholders approved Advisory vote on the compensation of the Company's named executive officers as disclosed in the proxy statement.
  - Proposal: say on pay
  - Outcome: passed
  source text: 5. The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. For: 40,373,427 Against: 1,745,379 Abstain: 62,342 Broker Non-Votes: 3,820,943
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388526000025/0001323885-26-000025-index.htm
- Shareholder Votes
  AtriCure, Inc. shareholders approved Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-12-31 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-12-31
  source text: 2. The stockholders approved the proposal to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. For: 43,617,566 Against: 2,327,505 Abstain: 57,020
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388526000025/0001323885-26-000025-index.htm
- Shareholder Votes
  AtriCure, Inc. shareholders approved Approve amendment to AtriCure, Inc. 2023 Stock Incentive Plan to increase number of shares by 1,500,000.
  - Proposal: equity plan
  - Outcome: passed
  source text: 3. The stockholders approved the amendment to the AtriCure, Inc. 2023 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 1,500,000 . For: 41,051,336 Against: 1,066,332 Abstain: 63,480 Broker Non-Votes: 3,820,943
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388526000025/0001323885-26-000025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.